glp-1 combination therapy Trial suggests combo cuts fat while preserving muscle in obesity Is Toujeo a GLP-1? The

In the U.S., about 75% of adults are overweight or obese. Children arent spared

Increased sweating affects some semaglutide users during treatment

Enjoy less hunger and more control, delivered in a refreshing blood orange, lemon, lime drink with only 20 calories!*

Blue Cross Blue Shield of Massachusetts will soon stop covering popular drugs for weight loss, like Ozempic.

Multivariate analysis showed no difference between placebo and liraglutide arms in HbA1c at 6 months (HbA1c:0.2mmol/mol, 11.3, 11.6, p=0.98) however, at 12 months HbA1c was significantly higher in the liraglutide arm (HbA1c:10.9mmol/mol, 1.1, 20.6, p=0.032)

But more and more research suggests that #amylin agonists might be the next big thing in #obesity and diabetes treatment